Immunovia /
Proteomedix
Immunovia to purchase materials from Proteomedix
Source for the buyer and target: Onconetix, Inc.
For the buyer and target.
“Under the terms of the agreement, Proteomedix will provide Immunovia with master cells required to produce antibodies related to three of the five biomarkers included in the PancreaSure test and a license for key intellectual property for the manufacturing of reagents used to measure these biomarkers, allowing Immunovia to purchase reagents directly from the supplier of Proteomedix.”
Published 22 Sep 2025
Open the sourceWhat happened
Immunovia, Inc. agreed to purchase materials from Proteomedix AG under an agreement signed on Sept. 17, 2025. The materials include hybridoma master cells used to produce antibodies. [01]
The agreement sets a purchase price of one hundred thousand USD ($100,000). It also provides for a license related to manufacturing reagents. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Immunovia to purchase materials from Proteomedix
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Agreement signed
“Immunovia to purchase materials from Proteomedix Immunovia, Inc. agreed to purchase materials from Proteomedix AG under an agreement signed on Sept. 17, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly